Ketamine's rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors

Abstract

Ketamine is shown to enhance excitatory synaptic drive in multiple brain areas, which is presumed to underlie its rapid antidepressant effects. Moreover, ketamine's therapeutic actions are likely mediated by enhancing neuronal Ca2+ signaling. However, ketamine is a noncompetitive NMDA receptor (NMDAR) antagonist that reduces excitatory synaptic transmission and postsynaptic Ca2+ signaling. Thus, it is a puzzling question how ketamine enhances glutamatergic and Ca2+ activity in neurons to induce rapid antidepressant effects while blocking NMDARs in the hippocampus. Here, we find that ketamine treatment in cultured mouse hippocampal neurons significantly reduces Ca2+ and calcineurin activity to elevate AMPA receptor (AMPAR) subunit GluA1 phosphorylation. This phosphorylation ultimately leads to the expression of Ca2+-Permeable, GluA2-lacking, and GluA1-containing AMPARs (CP-AMPARs). The ketamine-induced expression of CP-AMPARs enhances glutamatergic activity and glutamate receptor plasticity in cultured hippocampal neurons. Moreover, when a sub-anesthetic dose of ketamine is given to mice, it increases synaptic GluA1 levels, but not GluA2, and GluA1 phosphorylation in the hippocampus within one hour after treatment. These changes are likely mediated by ketamine-induced reduction of calcineurin activity in the hippocampus. Using the open field and tail suspension tests, we demonstrate that a low dose of ketamine rapidly reduces anxiety-like and depression-like behaviors in both male and female mice. However, when in vivo treatment of a CP-AMPAR antagonist abolishes the ketamine's effects on animals' behaviors. We thus discover that ketamine at the low dose promotes the expression of CP-AMPARs via reduction of calcineurin activity, which in turn enhances synaptic strength to induce rapid antidepressant actions.

Data availability

Source Data files have been provided for Figures (Fig. 1-6) that contain the numerical data used to generate the figures.

Article and author information

Author details

  1. Anastasiya Zaytseva

    Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Evelina Bouckova

    Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. McKennon J Wiles

    Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Madison H Wustrau

    Department of Biomedical Sciences, Colorado State University, Fort Collins, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Isabella G Schmidt

    Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Hadassah Mendez-Vazquez

    Department of Biomedical Sciences, Colorado State University, Fort Collins, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Latika Khatri

    Department of Cell Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Seonil Kim

    Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States
    For correspondence
    seonil.kim@colostate.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0451-2180

Funding

Colorado State University

  • Anastasiya Zaytseva
  • Evelina Bouckova
  • McKennon J Wiles
  • Madison H Wustrau
  • Isabella G Schmidt
  • Seonil Kim

Boettcher Foundation

  • Seonil Kim

NIH/NCATS Colorado CTSA Grant (UL1 TR002535)

  • Seonil Kim

NIA (R03AG072102)

  • Seonil Kim

BrightFocus Foundation

  • Seonil Kim

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Helen E Scharfman, Nathan Kline Institute and New York University Langone Medical Center, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#3408) of Colorado State University. The protocol was approved by the Committee on the Ethics of Animal Experiments of Colorado State University. All surgery was performed under urethane anesthesia, and every effort was made to minimize suffering.

Version history

  1. Preprint posted: December 5, 2022 (view preprint)
  2. Received: January 7, 2023
  3. Accepted: June 23, 2023
  4. Accepted Manuscript published: June 26, 2023 (version 1)
  5. Version of Record published: July 4, 2023 (version 2)

Copyright

© 2023, Zaytseva et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,870
    views
  • 227
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anastasiya Zaytseva
  2. Evelina Bouckova
  3. McKennon J Wiles
  4. Madison H Wustrau
  5. Isabella G Schmidt
  6. Hadassah Mendez-Vazquez
  7. Latika Khatri
  8. Seonil Kim
(2023)
Ketamine's rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
eLife 12:e86022.
https://doi.org/10.7554/eLife.86022

Share this article

https://doi.org/10.7554/eLife.86022

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Maximilian Nagel, Marco Niestroj ... Marc Spehr
    Research Article

    In most mammals, conspecific chemosensory communication relies on semiochemical release within complex bodily secretions and subsequent stimulus detection by the vomeronasal organ (VNO). Urine, a rich source of ethologically relevant chemosignals, conveys detailed information about sex, social hierarchy, health, and reproductive state, which becomes accessible to a conspecific via vomeronasal sampling. So far, however, numerous aspects of social chemosignaling along the vomeronasal pathway remain unclear. Moreover, since virtually all research on vomeronasal physiology is based on secretions derived from inbred laboratory mice, it remains uncertain whether such stimuli provide a true representation of potentially more relevant cues found in the wild. Here, we combine a robust low-noise VNO activity assay with comparative molecular profiling of sex- and strain-specific mouse urine samples from two inbred laboratory strains as well as from wild mice. With comprehensive molecular portraits of these secretions, VNO activity analysis now enables us to (i) assess whether and, if so, how much sex/strain-selective ‘raw’ chemical information in urine is accessible via vomeronasal sampling; (ii) identify which chemicals exhibit sufficient discriminatory power to signal an animal’s sex, strain, or both; (iii) determine the extent to which wild mouse secretions are unique; and (iv) analyze whether vomeronasal response profiles differ between strains. We report both sex- and, in particular, strain-selective VNO representations of chemical information. Within the urinary ‘secretome’, both volatile compounds and proteins exhibit sufficient discriminative power to provide sex- and strain-specific molecular fingerprints. While total protein amount is substantially enriched in male urine, females secrete a larger variety at overall comparatively low concentrations. Surprisingly, the molecular spectrum of wild mouse urine does not dramatically exceed that of inbred strains. Finally, vomeronasal response profiles differ between C57BL/6 and BALB/c animals, with particularly disparate representations of female semiochemicals.

    1. Neuroscience
    Kenta Abe, Yuki Kambe ... Tatsuo Sato
    Research Article

    Midbrain dopamine neurons impact neural processing in the prefrontal cortex (PFC) through mesocortical projections. However, the signals conveyed by dopamine projections to the PFC remain unclear, particularly at the single-axon level. Here, we investigated dopaminergic axonal activity in the medial PFC (mPFC) during reward and aversive processing. By optimizing microprism-mediated two-photon calcium imaging of dopamine axon terminals, we found diverse activity in dopamine axons responsive to both reward and aversive stimuli. Some axons exhibited a preference for reward, while others favored aversive stimuli, and there was a strong bias for the latter at the population level. Long-term longitudinal imaging revealed that the preference was maintained in reward- and aversive-preferring axons throughout classical conditioning in which rewarding and aversive stimuli were paired with preceding auditory cues. However, as mice learned to discriminate reward or aversive cues, a cue activity preference gradually developed only in aversive-preferring axons. We inferred the trial-by-trial cue discrimination based on machine learning using anticipatory licking or facial expressions, and found that successful discrimination was accompanied by sharper selectivity for the aversive cue in aversive-preferring axons. Our findings indicate that a group of mesocortical dopamine axons encodes aversive-related signals, which are modulated by both classical conditioning across days and trial-by-trial discrimination within a day.